Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELB139 crossover placebo-controlled study in panic disorder with CO2 challenge
2005-005708-17Phase 2Terminated
- Sponsor
- elbion
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ELB-139 in panic disorder (2 arms), sponsored by elbion. Primary endpoints: Subjective anxiety immediately after CO2 challenge after a single dose, Change in anxiety from pre- to post-CO2 challenge after a single dose and 2 more. Started Jan 2006; status: terminated.
02
Drugs
ELB-139
03
Conditions
panic disorder
Beyond the preview
Go deeper on 2005-005708-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005708-17.